Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 119.29 K1.51 M1.51 M588.77 K799.74 K 4.41 M Research & development ————— — Operating income -119.29 K-1.51 M-1.51 M-588.77 K-799.74 K -4.41 M Non-Operating Income, Total 740.88 K2.41 M2.44 M2.27 M2.09 M 9.21 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 740.88 K2.41 M2.44 M2.27 M2.09 M 9.21 M Unusual income/expense ————— — Pretax income 621.59 K895.78 K929.01 K1.68 M1.29 M 4.8 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 621.59 K895.78 K929.01 K1.68 M1.29 M 4.8 M Discontinued operations ————— — Net income 621.59 K895.78 K929.01 K1.68 M1.29 M 4.8 M Dilution adjustment 20.14 M2.41 M2.44 M2.27 M2.09 M 9.21 M Preferred dividends 20.14 M2.41 M2.44 M2.27 M2.09 M 9.21 M Diluted net income available to common stockholders 621.59 K895.78 K929.01 K1.68 M1.29 M 4.8 M Basic earnings per share (Basic EPS) 0.080.060.260.20.16 0.68 Diluted earnings per share (Diluted EPS) 0.080.060.220.240.16 0.68 Average basic shares outstanding 14.32 M22.84 M51.36 M54.18 M62.53 M — Diluted shares outstanding 15.01 M23.18 M51.81 M54.52 M62.53 M — EBITDA ————— — EBIT 486.23 K———— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —